Jinhai Medical Tech to Explore Equity Investment Opportunities With Digital Health China

MT Newswires Live11-03

Jinhai Medical Technology (HKG:2225) entered into a cooperation memorandum with Digital Health China Technologies to explore potential cooperation in business operations and equity investments, according to a Monday Hong Kong bourse filing.

The parties plan to explore merger and acquisition opportunities and equity investments, leveraging their respective resources, technologies, marketing and management capabilities.

Jinhai has exclusive negotiation rights with Digital Health on the proposed matters through March 31, 2027.

Any cooperation remains subject to further negotiations, due diligence, internal approvals, and formal agreements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment